DIVERSE EXPERIENCE

Diverse Experience. Full Range of Service.

With over 15 years of Phase I-IIa experience, PharmaNet has a solid track record of providing a full range of services, from protocol development and report preparation, to helping sponsors reduce costs, shorten timelines, and achieve quality data, leading you to quicker go/no-go decisions at the earliest possible stage.

PharmaNet has conducted hundreds of studies and files over 200 CTAs every year. With broad experience in a variety of study types, therapeutic areas, and dosage forms, our team has the expertise to conduct early stage studies that meet your specific requirements. PharmaNet develops creative and innovative study designs for first-in-man, proof-of-concept, drug drug interaction, SAD/MAD, and cardiac safety studies ensuring streamlined execution of any study, moving sponsors to proof-of-concept faster.

Study Types

  • First-in-man
  • PK/PD
  • Single/multiple ascending dose
  • Cardiac safety (QTc)
  • Safety/tolerability
  • Food/drug interactions
  • Genotyping
  • Age/gender
  • Bioavailability
  • Bioequivalence
  • Skin irritation/sensitization
  • New dose forms
  • Medical devices
  • Vaccines

Administration

  • Oral
  • Injectable (IV, IM, SC)
  • Rectal
  • Inhalation
  • Patch/Dermal

Therapeutic Indications